Introduction
neuronal loss is eliminated via cholesterol hydroxylation leading to the formation of 24S-hydroxycholesterol, the major elimination product of cerebral cholesterol.
The nuclear hormone receptor Retinoic X Receptor ␣ (RXR␣) is a member of the nuclear ligand-activated transcription factor family and belongs to the steroid hormone receptor super family. RXRs are important regulators of different pathways and are involved in cell proliferation, differentiation, and in glucose, fatty acid and cholesterol metabolism [11] . [12] [13] [14] [15] 
RXRs can function as homodimers or as heterodimers. Heterodimers of RXR␣ gene (RXRA) with the nuclear receptors liver X receptor (LXR) or peroxisome proliferator activated receptor (PPAR) have direct influence on cholesterol metabolism in that they influence expression of i.e. Apolipoprotein A1, APOE, ATP-binding cassette transporters (ABC-transporters) and sterol regulatory element-binding protein 1 (SREBP1), which are all key players in cholesterol homeostastis

. Sequence variations in RXRA might influence gene and protein function, leading to alterations in cholesterol metabolism and by this can influence the risk of AD.
RXRA is located at chromosome 9q34, nearby a putative hot spot for an AD risk gene [16, 17] . RXRA spans about 100 kilo bases and contains 10 exons. The promoter was just recently identified and characterized [18] . Several 
polymorphisms have been described in single-nucleotide polymorphism (SNP) databanks, but only few have been confirmed in human populations.
In general, studies on RXRA polymorphisms are scarce [19] [26] .
Genotyping of SNPs
The effect of association of RXRA single SNP and haplotype with lathosterol, 24S-hydroxycholesterol and cholesterol levels was tested by MANOVA using the APOE4 allele and age as covariates. Since it is known from the literature that there are differences in the levels of cholesterol and metabolites between AD patients and controls [3, 27] , separate analyses for each diagnosis group were performed. P-Values were set at two sided P < 0.05.
Results
Single locus analysis
Seven polymorphisms were identified in RXRA in our sample (Fig. 1) (Table 7) . Plasma cholesterol and lathosterol/cholesterol levels were neither influenced by the C allele nor by the TGC haplotype in nondemented persons (Table 7) .
In AD patients, levels of 24S-hydroxycholesterol/cholesterol were higher in carriers of the rs3132293 C allele (P ϭ 0.001) or the TGC haplotype (0.005). Levels of cholesterol or lathosterol/cholesterol were not influenced by any RXRA gene variant (Table 7) .
Discussion
Alterations of cholesterol metabolism contribute to AD risk and pathology [3, 28] . RXRA is a key regulator of cholesterol metabolism and the gene is located next a region on chromosome 9 comprising increased LOD scores in AD linkage analyses [17, 29] , making RXRA an ideal candidate for an AD risk gene.
We screened exons and flanking introns of RXRA and detected six polymorphisms with a frequency of >5% of the minor allele, which were included in our analyses. We selected only gene variants with a frequency of >5% for our study, and by this followed the common disease-common variant hypothesis [30, 31] [34, 35] and ABCA1 expression is regulated by heterodimers of RXRA with the nuclear receptor LXR [15] . Previous publications report on reduced levels of 24S-hydroxycholesterol in plasma of AD patients compared to controls [3, 36] [38] . However, in AD patients it has been shown that serum cholesterol levels are not influenced by the presence of the APOE4 allele [39, 40] . It 
